Mandate

Vinge has advised Gränges in connection with its rights issue

Vinge has advised Gränges AB (publ) in connection with a fully guaranteed rights issue of approximately SEK 1.7 billion before transaction costs.

The purpose of the rights issue is to finance the acquisition of Aluminium Konin, maintain Gränges’ financial strength and to finance future growth investments in line with Gränges’ strategy. The new shares subscribed for with subscription rights are expected to be admitted to trading on Nasdaq Stockholm on December 22, 2020.

Gränges is a leading global supplier of rolled aluminium products for heat exchanger applications, speciality packaging and niche markets. The company develops, produces and markets advanced materials that enhance efficiency in the customers’ manufacturing process and the performance of the final products. The company’s geographical markets are Europe, Asia and the Americas with production facilities in all three regions and a total annual capacity of 560,000 metric tonnes. Gränges has 2,400 employees and net sales of SEK 13 billion. The share is listed on Nasdaq Stockholm.

Vinge’s team primarily consisted of Jesper Schönbeck, Rikard Lindahl, Linnéa Sellström, Stephanie Stiernstedt, Anders Sundin Lundberg and Lorin Arabi (Capital Markets and Public M&A), Pauline Lagerstrand and Rebecka Målquist (Banking and Finance) as well as Maria Schultzberg and Henrik Wastenson (Tax).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025